Maurie Markman MD or, as I refer to him, "M&M" understands what counts.

What's that, you ask?

It's the value of “reassurance” given to a patient following a “positive” or “negative” test result tha
t suggests either the absence or lack of progression of a cancer, independent of any objective population-based clinical trial evidence that such a test result favorably affects survival.

M&M gets it.